Sheryl L. Chow

5.0k total citations · 2 hit papers
43 papers, 1.3k citations indexed

About

Sheryl L. Chow is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Sheryl L. Chow has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Cardiology and Cardiovascular Medicine, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Sheryl L. Chow's work include Heart Failure Treatment and Management (18 papers), Cardiovascular Function and Risk Factors (9 papers) and Potassium and Related Disorders (7 papers). Sheryl L. Chow is often cited by papers focused on Heart Failure Treatment and Management (18 papers), Cardiovascular Function and Risk Factors (9 papers) and Potassium and Related Disorders (7 papers). Sheryl L. Chow collaborates with scholars based in United States, Canada and Australia. Sheryl L. Chow's co-authors include Inder S. Anand, Michael R. Zile, James L. Januzzi, Alan S. Maisel, Barry Greenberg, Clyde W. Yancy, Gregg C. Fonarow, Biykem Bozkurt, Michael S. Kiernan and Rudolf A. de Boer and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Journal of Vascular Surgery.

In The Last Decade

Sheryl L. Chow

42 papers receiving 1.2k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association

2017 404 citations Sheryl L. Chow, Alan S. Maisel et al. Circulation profile →
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association

2023 283 citations Sadiya S. Khan, Josef Coresh et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sheryl L. Chow United States	16	758	195	184	179	134	43	1.3k
Bartosz Hudzik Poland	17	523 0.7×	239 1.2×	159 0.9×	121 0.7×	147 1.1×	110	1.2k
Vincent Bataille France	23	812 1.1×	346 1.8×	127 0.7×	224 1.3×	106 0.8×	66	1.5k
Luca Di Lullo Italy	26	876 1.2×	293 1.5×	399 2.2×	175 1.0×	255 1.9×	112	2.0k
Srikanth Yandrapalli United States	19	611 0.8×	258 1.3×	150 0.8×	161 0.9×	96 0.7×	94	1.0k
Pasquale Caldarola Italy	22	853 1.1×	367 1.9×	168 0.9×	107 0.6×	62 0.5×	111	1.3k
Timir K. Paul United States	18	778 1.0×	329 1.7×	242 1.3×	139 0.8×	218 1.6×	149	1.4k
Shari Targum United States	11	1.3k 1.7×	368 1.9×	242 1.3×	104 0.6×	112 0.8×	13	1.7k
Jie‐Lena Sun United States	21	779 1.0×	197 1.0×	145 0.8×	186 1.0×	250 1.9×	67	1.4k
Yun‐Jiu Cheng China	19	759 1.0×	205 1.1×	178 1.0×	121 0.7×	266 2.0×	70	1.6k
Leili Pourafkari Iran	17	668 0.9×	299 1.5×	210 1.1×	82 0.5×	95 0.7×	150	1.2k

Countries citing papers authored by Sheryl L. Chow

Since Specialization

Citations

This map shows the geographic impact of Sheryl L. Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheryl L. Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheryl L. Chow more than expected).

Fields of papers citing papers by Sheryl L. Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheryl L. Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheryl L. Chow. The network helps show where Sheryl L. Chow may publish in the future.

Co-authorship network of co-authors of Sheryl L. Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Sheryl L. Chow. A scholar is included among the top collaborators of Sheryl L. Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheryl L. Chow. Sheryl L. Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cao, Dazhe, Ann M. Arens, Sheryl L. Chow, et al.. (2025). Part 10: Adult and Pediatric Special Circumstances of Resuscitation: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 152(16_suppl_2). S578–S672. 4 indexed citations

Khan, Sadiya S., Khadijah Breathett, Lynne T. Braun, et al.. (2025). Risk-Based Primary Prevention of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 151(20). e1006–e1026. 10 indexed citations

Page, Robert L., et al.. (2024). Pharmacotherapy in the heart transplant recipient: A primer for nurse clinicians and pharmacists. Clinical Transplantation. 38(2). e15252–e15252. 2 indexed citations

Khan, Sadiya S., Josef Coresh, Michael Pencina, et al.. (2023). Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 148(24). 1982–2004. 283 indexed citations breakdown →

Kittleson, M., Daniel C. Brennan, Xingxing S. Cheng, et al.. (2023). Dual-Organ Transplantation: Indications, Evaluation, and Outcomes for Heart-Kidney and Heart-Liver Transplantation: A Scientific Statement From the American Heart Association. Circulation. 148(7). 622–636. 27 indexed citations

Chow, Sheryl L., Comilla Sasson, Ivor J. Benjamin, et al.. (2021). Opioid Use and Its Relationship to Cardiovascular Disease and Brain Health: A Presidential Advisory From the American Heart Association. Circulation. 144(13). 30 indexed citations

Chow, Sheryl L., Robert L. Page, & Christophe Depré. (2018). Role of ivabradine and heart rate lowering in chronic heart failure: guideline update. Expert Review of Cardiovascular Therapy. 16(7). 515–526. 3 indexed citations

Chow, Sheryl L., Alan S. Maisel, Inder S. Anand, et al.. (2017). Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 135(22). e1054–e1091. 404 indexed citations breakdown →

Chow, Sheryl L., Henry Krum, Stephen A. O’Barr, et al.. (2015). MARKERS OF EXTRACELLULAR MATRIX TURNOVER AND RISK OF DEATH IN PATIENTS WITH HEART FAILURE WITH PRESERVED EJECTION FRACTION: RESULTS FROM I-PRESERVE. Journal of the American College of Cardiology. 65(10). A969–A969. 2 indexed citations

10.

Heywood, J. Thomas, et al.. (2015). Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials. Expert Review of Cardiovascular Therapy. 13(7). 743–751. 5 indexed citations

11.

Tassell, Benjamín Van, et al.. (2015). Predicting therapeutic response in patients with heart failure: the story of C-reactive protein. Expert Review of Cardiovascular Therapy. 13(2). 153–161. 15 indexed citations

12.

Chow, Sheryl L., et al.. (2014). C-REACTIVE PROTEIN DOES NOT PREDICT THERAPEUTIC RESPONSE IN PATIENTS WITH HEART FAILURE: A META-ANALYSIS. Journal of the American College of Cardiology. 63(12). A787–A787. 1 indexed citations

13.

Kovanecz, Istvan, Dolores Vernet, Gaby Nolazco, et al.. (2012). Effects of sildenafil and/or muscle derived stem cells on myocardial infarction. Journal of Translational Medicine. 10(1). 159–159. 14 indexed citations

14.

Finks, Shannon W., et al.. (2012). Key Articles of Dietary Interventions that Influence Cardiovascular Mortality. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(4). e54–87. 22 indexed citations

15.

Chow, Sheryl L., et al.. (2010). Effect of iodixanol and ioxilan on QT interval and renal function in patients with systolic heart failure. International Journal of Cardiology. 154(1). 17–21. 2 indexed citations

16.

Jackevicius, Cynthia A., Robert L. Page, Sheryl L. Chow, et al.. (2008). High‐Impact Articles Related to the Management of Heart Failure: 2008 Update. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(1). 82–120. 7 indexed citations

17.

Chow, Sheryl L., et al.. (2007). Effect of Nesiritide Infusion Duration on Renal Function in Acutely Decompensated Heart Failure Patients. Annals of Pharmacotherapy. 41(4). 556–561. 11 indexed citations

18.

Donayre, Carlos E., et al.. (2006). The role of aortic neck dilation and elongation in the etiology of stent graft migration after endovascular abdominal aortic aneurysm repair with a passive fixation device. Journal of Vascular Surgery. 44(6). 1176–1181. 72 indexed citations

19.

Chow, Sheryl L., et al.. (2003). Correlation of Antifactor Xa Concentrations with Renal Function in Patients on Enoxaparin. The Journal of Clinical Pharmacology. 43(6). 586–590. 6 indexed citations

20.

Chow, Sheryl L., et al.. (2001). Acid‐Suppressive Therapy Use Associated with Antihypertensive Agents. The Journal of Clinical Pharmacology. 41(7). 750–756. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact